Skin News and Research

RSS

New Colombia Resources, Phoenix Tears Foundation to develop cannabis-based medicine for skin cancer

New Colombia Resources, Inc., a U.S. company with coal and other resource assets in Colombia, is pleased to announce an agreement of collaboration with the Phoenix Tears Foundation for the research and development of a cannabis based medicine to treat skin cancer in Colombia.

9 May 2014

Experimental antibody temporarily halts progression of neuroblastoma in children

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody produced at St. Jude Children's Research Hospital.

9 May 2014

Research on laser assisted drug delivery selected for April 2014 issue of LSM

Research conducted by Lindsay R. Sklar, M.D., Christopher T. Burnett, M.D., F.A.A.D., Jill S. Waibel, M.D., F.A.A.D., Ronald L. Moy, M.D., F.A.A.D., and David M. Ozog, M.D., F.A.A.D., was selected as Editor’s Choice for the April 2014 issue of Lasers in Surgery and Medicine.

9 May 2014

Study: Anti-inflammatory compound interleukin-10 plays crucial role in regenerative, scarless healing

The powerful anti-inflammatory compound interleukin-10 (IL-10) plays a crucial role in regenerative, scarless healing of fetal skin.

9 May 2014

Expanding Medicaid access increases use of subspecialty surgical services in New York State

Researchers in the department of surgery at the University of Michigan have found that expanding access to Medicaid in New York State increased beneficiaries' use of subspecialty surgical services.

8 May 2014

Researchers to develop unique technology to help physicians perform ultrasound-guided procedures involving needle placement

Significant funding from NIBIB has enabled researchers to develop a unique technology to help physicians perform ultrasound-guided procedures involving needle placement such as needle biopsies, central line insertion, and local anesthesia.

8 May 2014

Commonly used drug restores blood flow to oxygen-starved muscles of boys with muscular dystrophy

Cedars-Sinai Heart Institute researchers have found that a commonly prescribed drug restores blood flow to oxygen-starved muscles of boys with Duchenne muscular dystrophy, a genetic muscle-wasting disease that rarely is seen in girls but affects one in 3,500 male babies, profoundly shortening life expectancy. It is the most common fatal disease that affects children.

8 May 2014

Regular doctor visits may reduce melanoma mortality, says study

The risk of dying from the most dangerous type of skin cancer is significantly reduced with regular doctor visits, according to a Henry Ford Hospital study.

8 May 2014

MinuteClinic walk-in medical clinics open in central Georgia

The first MinuteClinic walk-in medical clinics in central Georgia have opened inside two CVS/pharmacy stores in Macon and one in Warner Robbins.

7 May 2014

New research reveals surprising facts about players who mask their identity online

A sexy wood elf with pointy ears. A hulking ogre with blue skin. An intimidating heroine with a buxom breastplate.

7 May 2014

State highlights: N.D. kids' program eligibility; Conn. nursing home transparency; La. hospital privatization

A selection of health policy stories from North Dakota, Connecticut, Louisiana, Colorado, New York, Kansas and Missouri.

7 May 2014

New data presented at EADO on investigational MEK inhibitor in combination with BRAF inhibitor for metastatic melanoma

New data have been presented for the first time at the European Association of Dermato Oncology (EADO) Congress today on the investigational MEK inhibitor cobimetinib (GDC-0973) in combination with BRAFV600 inhibitor Zelboraf® (vemurafenib) for metastatic melanoma, the most aggressive form of skin cancer. The findings illustrate that cobimetinib and vemurafenib can be safely co-administered and that the combination shows promising anti-tumour activity, with a median progression-free survival (mPFS) of 13.7 months for BRAF inhibitor-naive patients.1

7 May 2014

Surgical site infection guidelines provide real-world strategies to reduce number of infections

Surgical site infections (SSIs) are the most common and costly healthcare-associated infection (HAI) in the United States.

7 May 2014

ConvaTec posts strong financial results for FY 2013

ConvaTec, a privately-held medical products and technologies company, today announced strong financial results for the year ended December 31, 2013.

6 May 2014

FDA accepts Merck's MK-3475 BLA for review

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.

6 May 2014

Nu Skin Enterprises reports record revenue of $671.1M in first quarter 2014

Nu Skin Enterprises, Inc. today announced record first-quarter results with revenue of $671.1 million, a 24 percent improvement over the prior-year period. Revenue was negatively impacted 4 percent by foreign currency fluctuations.

6 May 2014

Tufts licenses novel silk technology for treatment of chronic skin wounds to Akeso Biomedical

Tufts University today announced that it has licensed a novel silk technology for the treatment of chronic skin wounds to Akeso Biomedical, Inc., an early stage medical device company.

6 May 2014

Covagen begins COVA322 Phase Ib/IIa study to treat patients with rheumatoid and psoriatic arthritis

Covagen today announced it has initiated a Phase Ib/IIa study with COVA322, a bispecific TNF/IL-17A inhibitor.

6 May 2014

College graduation is a time to reassess health insurance

College seniors need to add one item to their "to-do" list as graduation approaches: check out their insurance options, the Los Angeles Times reports. Also, KHN examines California Latinos' interest in getting health care in Mexico--even if they have purchased U.S. insurance.

6 May 2014

UH biomedical engineer receives ALR grant to study cause of lupus nephritis

In the U.S. alone, more than 1.5 million people have lupus, a chronic autoimmune disease in which the immune system turns against itself, attacking a person's healthy tissue, cells and organs. The symptoms can range from debilitating pain and fatigue to organ failure.

6 May 2014

Skin News and Research

New Colombia Resources, Phoenix Tears Foundation to develop cannabis-based medicine for skin cancer

Experimental antibody temporarily halts progression of neuroblastoma in children

Research on laser assisted drug delivery selected for April 2014 issue of LSM

Study: Anti-inflammatory compound interleukin-10 plays crucial role in regenerative, scarless healing

Expanding Medicaid access increases use of subspecialty surgical services in New York State

Researchers to develop unique technology to help physicians perform ultrasound-guided procedures involving needle placement

Commonly used drug restores blood flow to oxygen-starved muscles of boys with muscular dystrophy

Regular doctor visits may reduce melanoma mortality, says study

MinuteClinic walk-in medical clinics open in central Georgia

New research reveals surprising facts about players who mask their identity online

State highlights: N.D. kids' program eligibility; Conn. nursing home transparency; La. hospital privatization

New data presented at EADO on investigational MEK inhibitor in combination with BRAF inhibitor for metastatic melanoma

Surgical site infection guidelines provide real-world strategies to reduce number of infections

ConvaTec posts strong financial results for FY 2013

FDA accepts Merck's MK-3475 BLA for review

Nu Skin Enterprises reports record revenue of $671.1M in first quarter 2014

Tufts licenses novel silk technology for treatment of chronic skin wounds to Akeso Biomedical

Covagen begins COVA322 Phase Ib/IIa study to treat patients with rheumatoid and psoriatic arthritis

College graduation is a time to reassess health insurance

UH biomedical engineer receives ALR grant to study cause of lupus nephritis

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News